Halozyme Therapeutics Inc (HALO)

[rod5247]

"I seem to remember that Herceptin SC was in in 40 countries with an average market share around 35% last quarter. In any case, this sounds pretty good. Info about Mabthera sc is encouraging as well"

Q2 40 countries 30%, Q3 44-45 countries 35%, Q4 48 countries 40%.
Herceptin sc is progressing.

While the 30% conversion for MabThera sc is in line with Herceptin launch, the number of countries at 12 is lower. At least we are getting numbers and not going well, inline with, etc., etc. Need to see the launch country number start to take off in coming quarters.